Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
International Journal of Cancer
|
July 15, 1998
Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin
V J Möbus, R Moll, C D Gerharz, et al.
Lancet (London, England)
|
April 15, 1995
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer
I B Runnebaum, X W Tong, R König, et al.
Journal of Cancer Research and Clinical Oncology
|
February 27, 2023
Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany
I B Runnebaum, A Kather, J Vorwergk, et al.
Gynecologic Oncology
|
November 1, 1993
Chicken ovalbumin upstream promoter transcription factor (COUP-TF): an orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell lines
D G Kieback, I B Runnebaum, V J Moebus, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
January 19, 1999
p53 mutations and expression in ovarian cancers: correlation with overall survival
W H Wen, A Reles, I B Runnebaum, et al.
Anticancer Research
|
November 1, 1996
Chicken ovalbumin upstream promoter--transcription factor (COUP-TF) expression in human endometrial cancer cell lines
D G Kieback, T Levi, P Kohlberger, et al.
Geburtshilfe Und Frauenheilkunde
|
September 16, 2014
Standardised Registration of Surgical Complications in Laparoscopic-Gynaecological Therapeutic Procedures Using the Clavien-Dindo Classification
M P Radosa, G Meyberg-Solomayer, J Radosa, et al.
Anticancer Research
|
July 23, 1998
Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients
T Levy, I Agoulnik, E N Atkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer
A Reles, W H Wen, A Schmider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2017
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
V Möbus, C Jackisch, H J Lück, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
International Journal of Cancer
|
July 15, 1998
Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin
V J Möbus, R Moll, C D Gerharz, et al.
Lancet (London, England)
|
April 15, 1995
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer
I B Runnebaum, X W Tong, R König, et al.
Journal of Cancer Research and Clinical Oncology
|
February 27, 2023
Ovarian cancer prevention by opportunistic salpingectomy is a new de facto standard in Germany
I B Runnebaum, A Kather, J Vorwergk, et al.
Gynecologic Oncology
|
November 1, 1993
Chicken ovalbumin upstream promoter transcription factor (COUP-TF): an orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell lines
D G Kieback, I B Runnebaum, V J Moebus, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
January 19, 1999
p53 mutations and expression in ovarian cancers: correlation with overall survival
W H Wen, A Reles, I B Runnebaum, et al.
Anticancer Research
|
November 1, 1996
Chicken ovalbumin upstream promoter--transcription factor (COUP-TF) expression in human endometrial cancer cell lines
D G Kieback, T Levi, P Kohlberger, et al.
Geburtshilfe Und Frauenheilkunde
|
September 16, 2014
Standardised Registration of Surgical Complications in Laparoscopic-Gynaecological Therapeutic Procedures Using the Clavien-Dindo Classification
M P Radosa, G Meyberg-Solomayer, J Radosa, et al.
Anticancer Research
|
July 23, 1998
Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients
T Levy, I Agoulnik, E N Atkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer
A Reles, W H Wen, A Schmider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2017
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial
V Möbus, C Jackisch, H J Lück, et al.
Page
of 8